Xenetic Biosciences, Inc. SEC filings XBIO
Xenetic Biosciences, Inc. has 484 filings in SEC EDGAR's recent list, going back to Nov 21, 2011. Its latest annual report, Form 10-K, was filed on Mar 12, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 23, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Dec 11, 2025 | — |
| DEFA14A | Additional proxy material | Oct 31, 2025 | — |
| DEF 14A | Proxy statement | Oct 31, 2025 | Dec 11, 2025 |
| DEFA14A | Additional proxy material | Oct 31, 2024 | — |
| DEF 14A | Proxy statement | Oct 31, 2024 | Dec 11, 2024 |
| DEF 14A | Proxy statement | Nov 13, 2023 | Dec 6, 2023 |
| DEFA14A | Additional proxy material | Oct 17, 2022 | — |
| DEF 14A | Proxy statement | Oct 17, 2022 | Dec 7, 2022 |
| PRE 14A | Preliminary proxy statement | Oct 3, 2022 | Dec 7, 2022 |
| DEFA14A | Additional proxy material | Dec 2, 2021 | — |
| DEF 14A | Proxy statement | Oct 15, 2021 | Dec 7, 2021 |
| DEF 14A | Proxy statement | Oct 13, 2020 | Dec 4, 2020 |
| PRE 14A | Preliminary proxy statement | Sep 30, 2020 | Dec 4, 2020 |
| DEF 14A | Proxy statement | Nov 8, 2019 | Dec 4, 2019 |
| DEF 14A | Proxy statement | Nov 13, 2018 | Nov 28, 2018 |
| DEF 14A | Proxy statement | Jun 22, 2017 | Jul 18, 2017 |
| PRE 14A | Preliminary proxy statement | Jun 9, 2017 | Jul 18, 2017 |
| DEF 14C | Information statement | May 2, 2017 | Feb 10, 2017 |
| PRE 14C | Filing | Mar 22, 2017 | Feb 10, 2017 |
Showing 19 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- XBIO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Framingham, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1534525
- Former names
- General Sales & Leasing, Inc. (until Jan 10, 2014); GENERAL AIRCRAFT INC. (until Feb 12, 2013)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.